Behind The Knife: The Surgery Podcast4 Maalis 2024

Journal Review in Surgical Oncology: Gastrointestinal Stromal Tumors (GISTs)

Join the Behind the Knife Surgical Oncology Team as we discuss “One versus Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial,” the randomized trial guiding duration of imatinib treatment for gastrointestinal stromal tumors (GIST).

Hosts:
- Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center.
- Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist and current HPB fellow at MD Anderson.
- Connor Chick, MD (@connor_chick) is a Surgical Oncology fellow at Ohio State University.
- Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a PGY-6 General Surgery resident at Brooke Army Medical Center.
- Beth (Elizabeth) Carpenter, MD (@elizcarpenter16) is a PGY-5 General Surgery resident at Brooke Army Medical Center.

Learning Objectives:

In this episode, we discuss the article “One versus Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial” published in JAMA in 2012. This study demonstrated that 3 years of imatinib led to improved recurrence-free and overall survival compared to 1 year.

Links to Paper Referenced in this Episode
https://jamanetwork.com/journals/jama/fullarticle/1105116

***Fellowship Application - https://forms.gle/5fbYJ1JXv3ijpgCq9***

Please visit https://app.behindtheknife.org/home to access other high-yield surgical education podcasts, videos and more.

If you liked this episode, check out our recent episodes here https://app.behindtheknife.org/listen

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(500)

Journal Review in Hernia Surgery: What is Bioresorbable Mesh and Is It Worth It?

Join our OHSY Hernia team to review the current landscape of bioresorbable meshes and a conversation considering “are they worth it?"Hosts: Dr. Maggie Bosley - @MBosleyMD Dr. Sean Orenstein - @Orenst...

23 Heinä 0s

Journal Review in Colorectal Surgery: ctDNA in Colorectal Cancer and Anal Squamous Cell Cancer

Circulating tumor DNA (ctDNA), a minimally invasive blood-based biomarker, has emerged as one of the most promising advances in cancer surveillance. Today, we will explore how ctDNA is transforming th...

20 Heinä 41min

Mattox Conference Pro-Con Debate 2026: REBOA

Every spring for over 50 years, the Trauma, Critical Care, and Acute Care Surgery conference, best known simply as the MATTOX conference, is held in Las Vegas (https://www.trauma-criticalcare.com/). ...

17 Heinä 28min

Mattox Conference Pro-Con Debate 2026: Management of Pediatric Pancreatic Injuries

16 Heinä 26min

Wellbeing and Mental Health in Surgeons

Join us as we discuss research on mental health and wellbeing in the surgical workforce with Drs. Yang and Collins. The episode explores key findings from recent national surveys showing that nearly o...

13 Heinä 41min

OBGYN Oral Board Review - Sample Episode: Intraoperative and Postoperative Wound

INTRODUCING Behind the Knife OBGYN Oral Board Review!The oral boards aren't just about knowledge—they are about executing under pressure. This course is designed to give you the structure and confiden...

9 Heinä 23min

EPA Playbook: Blunt or Penetrating Trauma

Join Drs. Georgoff, Burke, and Premkumar in this episode of the EPA Playbook as they break down a practical, repeatable framework for managing patients in the trauma bay, one of the most high-pressure...

7 Heinä 50min

EPA Playbook: Small Bowel Obstruction

Join Drs. Georgoff, Burke, and Premkumar in this episode of EPA Playbook, where we tackle the evaluation and management of small bowel obstruction. Through a realistic series of scenarios, we walk ste...

6 Heinä 24min